Skip to main content

Organon & Co.

For the period ended Mar 31, 2024. Filed May 3, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 3, 2024

OGN$13.85-0.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

(Unaudited, $ in millions, except shares in thousands and per share amounts)

Common Stock · Additional Paid-In Capital · Retained Earnings and (Accumulated Deficit) · AccumulatedOtherComprehensiveLoss · Total
Shares · Par Value
Balance at January 1, 2023254,370$3$—$(331)$(564)$(892)
Net income———177—177
Other comprehensive income, net of taxes————3030
Cash dividends declared on common stock ($0.28 per share)———(73)—(73)
Stock-based compensation plans and other62——21—21
Balance at March 31, 2023254,432$3$—$(206)$(534)$(737)
Balance at January 1, 2024255,626$3$25$443$(541)$(70)
Net income———201—201
Other comprehensive loss, net of taxes————(36)(36)
Cash dividends declared on common stock ($0.28 per share)———(71)—(71)
Stock-based compensation plans and other221—24——24
Balance at March 31, 2024255,847$3$49$573$(577)$48

-6-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.